citalopram has been researched along with Acquired Immunodeficiency Syndrome in 3 studies
Citalopram: A furancarbonitrile that is one of the serotonin uptake inhibitors used as an antidepressant. The drug is also effective in reducing ethanol uptake in alcoholics and is used in depressed patients who also suffer from TARDIVE DYSKINESIA in preference to tricyclic antidepressants, which aggravate dyskinesia.
citalopram : A racemate comprising equimolar amounts of (R)-citalopram and its enantiomer, escitalopram. It is used as an antidepressant, although only escitalopram is active.
1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-2-benzofuran-5-carbonitrile : A nitrile that is 1,3-dihydro-2-benzofuran-5-carbonitrile in which one of the hydrogens at position 1 is replaced by a p-fluorophenyl group, while the other is replaced by a 3-(dimethylamino)propyl group.
Acquired Immunodeficiency Syndrome: An acquired defect of cellular immunity associated with infection by the human immunodeficiency virus (HIV), a CD4-positive T-lymphocyte count under 200 cells/microliter or less than 14% of total lymphocytes, and increased susceptibility to opportunistic infections and malignant neoplasms. Clinical manifestations also include emaciation (wasting) and dementia. These elements reflect criteria for AIDS as defined by the CDC in 1993.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To test the hypothesis that the selective serotonin reuptake inhibitor (SSRI) citalopram would down-regulate human immunodeficiency virus (HIV) infectivity and that the greatest effects would be seen in people with depression." | 3.76 | Selective serotonin reuptake inhibitor suppression of HIV infectivity and replication. ( Benton, T; Blume, J; Douglas, SD; Dubé, B; Evans, DL; Gettes, DR; Lynch, K; Metzger, DS; Ping Lai, J; Tustin, NB, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hoare, J | 1 |
| Carey, P | 1 |
| Joska, JA | 1 |
| Carrara, H | 1 |
| Sorsdahl, K | 1 |
| Stein, DJ | 1 |
| Benton, T | 2 |
| Lynch, K | 1 |
| Dubé, B | 2 |
| Gettes, DR | 2 |
| Tustin, NB | 2 |
| Ping Lai, J | 1 |
| Metzger, DS | 1 |
| Blume, J | 1 |
| Douglas, SD | 2 |
| Evans, DL | 2 |
| Lynch, KG | 1 |
| Lai, JP | 1 |
| Metzger, D | 1 |
2 trials available for citalopram and Acquired Immunodeficiency Syndrome
| Article | Year |
|---|---|
Escitalopram treatment of depression in human immunodeficiency virus/acquired immunodeficiency syndrome: a randomized, double-blind, placebo-controlled study.
Topics: Acquired Immunodeficiency Syndrome; Adult; Citalopram; Depressive Disorder, Major; Double-Blind Meth | 2014 |
Selective serotonin reuptake inhibitor and substance P antagonist enhancement of natural killer cell innate immunity in human immunodeficiency virus/acquired immunodeficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Adult; Biphenyl Compounds; Citalopram; Depressive Disorder; Depr | 2008 |
1 other study available for citalopram and Acquired Immunodeficiency Syndrome
| Article | Year |
|---|---|
Selective serotonin reuptake inhibitor suppression of HIV infectivity and replication.
Topics: Acquired Immunodeficiency Syndrome; Adult; CD8-Positive T-Lymphocytes; Cell Line; Cells, Cultured; C | 2010 |